Human Beta-defensin 1 in Vitiligo
NCT03832751 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2019-02-06
Summary
There is a need to know the role of human beta defensin-1 in vitiligo pathogenesis and the probability of finding newer and effective therapy for vitiligo in the future.
Conditions
- Vitiligo
Interventions
- OTHER
-
skin biopsy before and after NB-UVB phototherapy
skin biopsy before and after NB-UVB phototherapy to measure tissue human beta-defensin 1
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
More Related Trials
-
Epidermal Cell Transplantation in Vitiligo Skin
NCT01629979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
Janus Kinase 1 in Vitiligo & Psoriasis
NCT03762551 ·Status: COMPLETED ·Phase: NA
-
Photoprotection Habits in Patients With Vitiligo
NCT03323125 ·Status: COMPLETED
-
Prostaglandin F2-alpha (PGF2α) in Vitiligo
NCT03755830 ·Status: UNKNOWN ·Phase: NA
-
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
NCT06546059 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
NCT02002897 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Scanoskin for the Assessment of Vitiligo
NCT03133871 ·Status: COMPLETED
-
Vitiligo, New Treatment and Serum s100B
NCT06768840 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo
NCT03371758 ·Status: UNKNOWN ·Phase: NA
-
Leucotrichia in Vitiligo
NCT03402633 ·Status: COMPLETED
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN
-
UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
NCT04875078 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Stress Response Pathways in Vitiligo
NCT02797574 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis
NCT00628797 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NCT04922736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Resident Memory T Cells in Vitiligo
NCT05223738 ·Status: UNKNOWN
-
The Validation of New Photographic Technology for Assessing Skin Lesions
NCT06663241 ·Status: COMPLETED
-
Gene Polymorphism in Tinea Versicolor
NCT04769804 ·Status: UNKNOWN
-
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
NCT06584643 ·Status: NOT_YET_RECRUITING